Showing 131-140 of 1560 results for "".
Building a Multidisciplinary Care Team for Sickle Cell Disease Patients
https://reachmd.com/programs/project-oncology/building-a-multidisciplinary-care-team-for-sickle-cell-disease-patients/36450/Sickle cell disease extends far beyond hematology, impacting multiple organ systems and requiring truly comprehensive care. That's why collaboration across specialties, as well as the integration of psychosocial support, school coordination, and structured transition planning, can improve patients'Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care
https://reachmd.com/programs/project-oncology/examining-barriers-and-facilitators-in-pediatric-sickle-cell-disease-care/36235/Families of children with sickle cell disease have noted both an abundance of support and significant obstacles when accessing care, ranging from knowledgeable providers and flexible scheduling to transportation concerns and insurance holdups. Joining Ashley Baker to discuss their recent research onPediatric Sickle Cell Disease: Analyzing Trends in Medication Utilization
https://reachmd.com/programs/project-oncology/pediatric-sickle-cell-disease-analyzing-trends-in-medication-utilization/36515/Pediatric sickle cell disease treatment, particularly the use of hydroxyurea, NSAIDs, and opioids, has evolved in response to clinical guidelines and regulatory shifts, but gaps still remain in how children receive essential medications. Joining Dr. Charles Turck to discuss these national prescribinNew Non-Invasive Test Predicts Eczema Risk in Newborns
https://reachmd.com/programs/dermconsult/new-non-invasive-test-predicts-eczema-risk-in-newborns/14248/Can a new test predict the severity of eczema during the first year of a child’s life? Find out how it works.U.S. Researchers Use Gene Editing to Remove HIV from 100% of Cells
https://reachmd.com/programs/clinicians-roundtable/us-researchers-use-gene-editing-remove-hiv-from-100-cells/8036/A team of researchers at Temple University, headed by Dr. Kamel Khalili, removed HIV from cells using CRISPR/Cas-9 gene editing. Will this cure AIDS?CLINICAL IMPLICATIONS OF ASCT Research
https://reachmd.com/programs/clinicians-roundtable/clinical-implications-of-asct-research/1114/Tens of thousands of autologous stem cell transplants are performed each year to treat blood cancer. Is there a way to increase the long term success rates?A Human CLINICAL Trial of Engineered ASCT
https://reachmd.com/programs/clinicians-roundtable/a-human-clinical-trial-of-engineered-asct-1/1115/Tens of thousands of autologous stem cell transplants are performed each year to treat blood cancer. Is there a way to increase the long term success rates?A Human CLINICAL Trial of Engineered ASCT
https://reachmd.com/programs/clinicians-roundtable/a-human-clinical-trial-of-engineered-asct/1113/Tens of thousands of autologous stem cell transplants are performed each year to treat blood cancer. Is there a way to increase the long term success rates?Optimizing Second-Line CAR T Decisions in R/R Large B-Cell Lymphoma
https://reachmd.com/programs/project-oncology/optimizing-second-line-car-t-decisions-in-rr-large-b-cell-lymphoma/33231/The treatment landscape for relapsed/refractory (R/R) large B-cell lymphoma has significantly shifted, with CAR T-cell therapies now offering curative potential in the second-line setting. But these advances also raise important questions, like how to identify the right candidates and navigate logisReducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
https://reachmd.com/programs/frontlines-prostate-cancer/reducing-prostate-cancer-cell-production-the-role-of-bipolar-androgen-therapy/32217/Bipolar androgen therapy is a treatment approach that uses high doses of testosterone to potentially suppress the growth of cells in advanced prostate cancer patients. Here to discuss the findings from recent studies on bipolar androgen therapy and the potential mechanisms behind this approach is Dr